2017
Pharmacogenomics of 17‐alpha hydroxyprogesterone caproate for recurrent preterm birth: a case–control study
Manuck T, Watkins W, Esplin, Biggio J, Bukowski R, Parry S, Zhan H, Huang H, Andrews W, Saade G, Sadovsky Y, Reddy U, Ilekis J, Yandell M, Varner M, Jorde L, Research T. Pharmacogenomics of 17‐alpha hydroxyprogesterone caproate for recurrent preterm birth: a case–control study. BJOG An International Journal Of Obstetrics & Gynaecology 2017, 125: 343-350. PMID: 28139890, DOI: 10.1111/1471-0528.14485.Peer-Reviewed Original ResearchConceptsRecurrent preterm birthPreterm birthSuccessful prolongationDefinition ADefinition BSingleton spontaneous preterm birthSpontaneous preterm birthTertiary care centerCase-control studyWhole-exome sequencingUntreated pregnanciesGestational ageHydroxyprogesterone caproateSignificant prolongationPregnancyExome sequencingProlongationWomenPharmacogenetic genesBirthGene ontology pathwaysIntegrated DiscoveryOntology pathwaysNovel analytic approach
2011
The Stillbirth Collaborative Research Network Postmortem Examination Protocol
Pinar H, Koch M, Hawkins H, Heim-Hall J, Abramowsky C, Thorsten V, Carpenter M, Zhou H, Reddy U. The Stillbirth Collaborative Research Network Postmortem Examination Protocol. American Journal Of Perinatology 2011, 29: 187-202. PMID: 21815127, PMCID: PMC4320124, DOI: 10.1055/s-0031-1284228.Peer-Reviewed Original ResearchConceptsPostmortem examinationStillborn infantsEunice Kennedy Shriver National InstitutePerinatal postmortem examinationCauses of stillbirthTertiary care centerPopulation-based studyCare centerPerinatal pathologistsMedical CenterChild healthStillbirthExamination protocolNational InstituteStandardized approachInfantsResearch NetworkWomenTotalPM protocolPathogenesisCliniciansNICHDCenterNovel testing